The global Interventional Oncology market size was valued at USD 1738.2 million in 2023 and is forecast to a readjusted size of USD 2246.4 million by 2030 with a CAGR of 3.7% during review period.
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
The report includes an overview of the development of the Interventional Oncology industry chain, the market status of Liver Cancer (Ablation Devices, Embolization Devices), Lung Cancer (Ablation Devices, Embolization Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Interventional Oncology.
Regionally, the report analyzes the Interventional Oncology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Interventional Oncology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Interventional Oncology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Interventional Oncology industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Ablation Devices, Embolization Devices).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Interventional Oncology market.
Regional Analysis: The report involves examining the Interventional Oncology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Interventional Oncology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Interventional Oncology:
Company Analysis: Report covers individual Interventional Oncology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Interventional Oncology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Liver Cancer, Lung Cancer).
Technology Analysis: Report covers specific technologies relevant to Interventional Oncology. It assesses the current state, advancements, and potential future developments in Interventional Oncology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Interventional Oncology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Interventional Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Ablation Devices
Embolization Devices
Support Devices
Market segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Market segment by players, this report covers
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Interventional Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Interventional Oncology, with revenue, gross margin and global market share of Interventional Oncology from 2019 to 2024.
Chapter 3, the Interventional Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Interventional Oncology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Interventional Oncology.
Chapter 13, to describe Interventional Oncology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Interventional Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Interventional Oncology by Type
1.3.1 Overview: Global Interventional Oncology Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Interventional Oncology Consumption Value Market Share by Type in 2023
1.3.3 Ablation Devices
1.3.4 Embolization Devices
1.3.5 Support Devices
1.4 Global Interventional Oncology Market by Application
1.4.1 Overview: Global Interventional Oncology Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Liver Cancer
1.4.3 Lung Cancer
1.4.4 Kidney Cancer
1.4.5 Bone Cancer
1.4.6 Breast Cancer
1.4.7 Prostate Cancer
1.4.8 Pancreatic Cancer
1.5 Global Interventional Oncology Market Size & Forecast
1.6 Global Interventional Oncology Market Size and Forecast by Region
1.6.1 Global Interventional Oncology Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Interventional Oncology Market Size by Region, (2019-2030)
1.6.3 North America Interventional Oncology Market Size and Prospect (2019-2030)
1.6.4 Europe Interventional Oncology Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Interventional Oncology Market Size and Prospect (2019-2030)
1.6.6 South America Interventional Oncology Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Interventional Oncology Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Interventional Oncology Product and Solutions
2.1.4 Boston Scientific Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Boston Scientific Recent Developments and Future Plans
2.2 BTG
2.2.1 BTG Details
2.2.2 BTG Major Business
2.2.3 BTG Interventional Oncology Product and Solutions
2.2.4 BTG Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BTG Recent Developments and Future Plans
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Interventional Oncology Product and Solutions
2.3.4 Medtronic Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Medtronic Recent Developments and Future Plans
2.4 Merit Medical
2.4.1 Merit Medical Details
2.4.2 Merit Medical Major Business
2.4.3 Merit Medical Interventional Oncology Product and Solutions
2.4.4 Merit Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merit Medical Recent Developments and Future Plans
2.5 Terumo
2.5.1 Terumo Details
2.5.2 Terumo Major Business
2.5.3 Terumo Interventional Oncology Product and Solutions
2.5.4 Terumo Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Terumo Recent Developments and Future Plans
2.6 Accuray
2.6.1 Accuray Details
2.6.2 Accuray Major Business
2.6.3 Accuray Interventional Oncology Product and Solutions
2.6.4 Accuray Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Accuray Recent Developments and Future Plans
2.7 Alpinion Medical Systems
2.7.1 Alpinion Medical Systems Details
2.7.2 Alpinion Medical Systems Major Business
2.7.3 Alpinion Medical Systems Interventional Oncology Product and Solutions
2.7.4 Alpinion Medical Systems Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Alpinion Medical Systems Recent Developments and Future Plans
2.8 Angiodynamics
2.8.1 Angiodynamics Details
2.8.2 Angiodynamics Major Business
2.8.3 Angiodynamics Interventional Oncology Product and Solutions
2.8.4 Angiodynamics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Angiodynamics Recent Developments and Future Plans
2.9 Atricure
2.9.1 Atricure Details
2.9.2 Atricure Major Business
2.9.3 Atricure Interventional Oncology Product and Solutions
2.9.4 Atricure Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Atricure Recent Developments and Future Plans
2.10 Baylis Medical
2.10.1 Baylis Medical Details
2.10.2 Baylis Medical Major Business
2.10.3 Baylis Medical Interventional Oncology Product and Solutions
2.10.4 Baylis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Baylis Medical Recent Developments and Future Plans
2.11 Bovie Medical
2.11.1 Bovie Medical Details
2.11.2 Bovie Medical Major Business
2.11.3 Bovie Medical Interventional Oncology Product and Solutions
2.11.4 Bovie Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bovie Medical Recent Developments and Future Plans
2.12 Brainlab
2.12.1 Brainlab Details
2.12.2 Brainlab Major Business
2.12.3 Brainlab Interventional Oncology Product and Solutions
2.12.4 Brainlab Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Brainlab Recent Developments and Future Plans
2.13 Bsd Medical
2.13.1 Bsd Medical Details
2.13.2 Bsd Medical Major Business
2.13.3 Bsd Medical Interventional Oncology Product and Solutions
2.13.4 Bsd Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bsd Medical Recent Developments and Future Plans
2.14 C. R. Bard
2.14.1 C. R. Bard Details
2.14.2 C. R. Bard Major Business
2.14.3 C. R. Bard Interventional Oncology Product and Solutions
2.14.4 C. R. Bard Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 C. R. Bard Recent Developments and Future Plans
2.15 C2 Therapeutics
2.15.1 C2 Therapeutics Details
2.15.2 C2 Therapeutics Major Business
2.15.3 C2 Therapeutics Interventional Oncology Product and Solutions
2.15.4 C2 Therapeutics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 C2 Therapeutics Recent Developments and Future Plans
2.16 Cardiofocus
2.16.1 Cardiofocus Details
2.16.2 Cardiofocus Major Business
2.16.3 Cardiofocus Interventional Oncology Product and Solutions
2.16.4 Cardiofocus Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Cardiofocus Recent Developments and Future Plans
2.17 Cook Medical
2.17.1 Cook Medical Details
2.17.2 Cook Medical Major Business
2.17.3 Cook Medical Interventional Oncology Product and Solutions
2.17.4 Cook Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Cook Medical Recent Developments and Future Plans
2.18 Eckert And Ziegler Bebig
2.18.1 Eckert And Ziegler Bebig Details
2.18.2 Eckert And Ziegler Bebig Major Business
2.18.3 Eckert And Ziegler Bebig Interventional Oncology Product and Solutions
2.18.4 Eckert And Ziegler Bebig Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Eckert And Ziegler Bebig Recent Developments and Future Plans
2.19 Edap Tms
2.19.1 Edap Tms Details
2.19.2 Edap Tms Major Business
2.19.3 Edap Tms Interventional Oncology Product and Solutions
2.19.4 Edap Tms Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Edap Tms Recent Developments and Future Plans
2.20 Elekta
2.20.1 Elekta Details
2.20.2 Elekta Major Business
2.20.3 Elekta Interventional Oncology Product and Solutions
2.20.4 Elekta Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Elekta Recent Developments and Future Plans
2.21 Galil Medical
2.21.1 Galil Medical Details
2.21.2 Galil Medical Major Business
2.21.3 Galil Medical Interventional Oncology Product and Solutions
2.21.4 Galil Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Galil Medical Recent Developments and Future Plans
2.22 Healthtronics
2.22.1 Healthtronics Details
2.22.2 Healthtronics Major Business
2.22.3 Healthtronics Interventional Oncology Product and Solutions
2.22.4 Healthtronics Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Healthtronics Recent Developments and Future Plans
2.23 Insightec
2.23.1 Insightec Details
2.23.2 Insightec Major Business
2.23.3 Insightec Interventional Oncology Product and Solutions
2.23.4 Insightec Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Insightec Recent Developments and Future Plans
2.24 Medwaves
2.24.1 Medwaves Details
2.24.2 Medwaves Major Business
2.24.3 Medwaves Interventional Oncology Product and Solutions
2.24.4 Medwaves Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Medwaves Recent Developments and Future Plans
2.25 Mermaid Medical
2.25.1 Mermaid Medical Details
2.25.2 Mermaid Medical Major Business
2.25.3 Mermaid Medical Interventional Oncology Product and Solutions
2.25.4 Mermaid Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Mermaid Medical Recent Developments and Future Plans
2.26 Microsulis Medical
2.26.1 Microsulis Medical Details
2.26.2 Microsulis Medical Major Business
2.26.3 Microsulis Medical Interventional Oncology Product and Solutions
2.26.4 Microsulis Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.26.5 Microsulis Medical Recent Developments and Future Plans
2.27 Monteris Medical
2.27.1 Monteris Medical Details
2.27.2 Monteris Medical Major Business
2.27.3 Monteris Medical Interventional Oncology Product and Solutions
2.27.4 Monteris Medical Interventional Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.27.5 Monteris Medical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Interventional Oncology Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Interventional Oncology by Company Revenue
3.2.2 Top 3 Interventional Oncology Players Market Share in 2023
3.2.3 Top 6 Interventional Oncology Players Market Share in 2023
3.3 Interventional Oncology Market: Overall Company Footprint Analysis
3.3.1 Interventional Oncology Market: Region Footprint
3.3.2 Interventional Oncology Market: Company Product Type Footprint
3.3.3 Interventional Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Interventional Oncology Consumption Value and Market Share by Type (2019-2024)
4.2 Global Interventional Oncology Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Interventional Oncology Consumption Value Market Share by Application (2019-2024)
5.2 Global Interventional Oncology Market Forecast by Application (2025-2030)
6 North America
6.1 North America Interventional Oncology Consumption Value by Type (2019-2030)
6.2 North America Interventional Oncology Consumption Value by Application (2019-2030)
6.3 North America Interventional Oncology Market Size by Country
6.3.1 North America Interventional Oncology Consumption Value by Country (2019-2030)
6.3.2 United States Interventional Oncology Market Size and Forecast (2019-2030)
6.3.3 Canada Interventional Oncology Market Size and Forecast (2019-2030)
6.3.4 Mexico Interventional Oncology Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Interventional Oncology Consumption Value by Type (2019-2030)
7.2 Europe Interventional Oncology Consumption Value by Application (2019-2030)
7.3 Europe Interventional Oncology Market Size by Country
7.3.1 Europe Interventional Oncology Consumption Value by Country (2019-2030)
7.3.2 Germany Interventional Oncology Market Size and Forecast (2019-2030)
7.3.3 France Interventional Oncology Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Interventional Oncology Market Size and Forecast (2019-2030)
7.3.5 Russia Interventional Oncology Market Size and Forecast (2019-2030)
7.3.6 Italy Interventional Oncology Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Interventional Oncology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Interventional Oncology Market Size by Region
8.3.1 Asia-Pacific Interventional Oncology Consumption Value by Region (2019-2030)
8.3.2 China Interventional Oncology Market Size and Forecast (2019-2030)
8.3.3 Japan Interventional Oncology Market Size and Forecast (2019-2030)
8.3.4 South Korea Interventional Oncology Market Size and Forecast (2019-2030)
8.3.5 India Interventional Oncology Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Interventional Oncology Market Size and Forecast (2019-2030)
8.3.7 Australia Interventional Oncology Market Size and Forecast (2019-2030)
9 South America
9.1 South America Interventional Oncology Consumption Value by Type (2019-2030)
9.2 South America Interventional Oncology Consumption Value by Application (2019-2030)
9.3 South America Interventional Oncology Market Size by Country
9.3.1 South America Interventional Oncology Consumption Value by Country (2019-2030)
9.3.2 Brazil Interventional Oncology Market Size and Forecast (2019-2030)
9.3.3 Argentina Interventional Oncology Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Interventional Oncology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Interventional Oncology Market Size by Country
10.3.1 Middle East & Africa Interventional Oncology Consumption Value by Country (2019-2030)
10.3.2 Turkey Interventional Oncology Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Interventional Oncology Market Size and Forecast (2019-2030)
10.3.4 UAE Interventional Oncology Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Interventional Oncology Market Drivers
11.2 Interventional Oncology Market Restraints
11.3 Interventional Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Interventional Oncology Industry Chain
12.2 Interventional Oncology Upstream Analysis
12.3 Interventional Oncology Midstream Analysis
12.4 Interventional Oncology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
听
听
*If Applicable.
